Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Marked paraneoplastic leukemoid reaction in a patient with mesothelioma mimicking a myeloid neoplasm

Beenu Thakral, Sanam Loghavi

Blood (2020) 135 (6): 457.

https://doi.org/10.1182/blood.2019003936

Published: 2020

Journal Articles

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

Eider F Moreno Cortes, MD, Caleb K Stein, PhD, Paula A Lengerke Diaz, MD, Cesar A Ramirez-Segura, BS, PhD, Januario E. Castro, MD

Blood (2019) 134 (Supplement_1): 5629.

https://doi.org/10.1182/blood-2019-132273

Published: 2019

Journal Articles

Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia

Allison Kaeding, MD, Katherine Tarlock, MD, Sonali Barwe, PhD, Anilkumar Gopalakrisnapillai, PhD, Todd A Alonzo, PhD, Robert B Gerbing, Michael R. Loken, PhD, Rhonda E. Ries, MA, Laura Pardo, Cassie Chou, MD PhD, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 2641.

https://doi.org/10.1182/blood.V130.Suppl_1.2641.2641

Published: 2017

Journal Articles

10-Year Outcome of Chronic Myeloid Leukemia Patients Resistant to Frontline Imatinib

Simone Claudiani, MD, Adi Shacham Abulafia, Ira Sabli, BSc, Richard Szydlo, PhD, Dragana Milojkovic, MBBS, PhD, George Nesr, MD, Renuka Palanicawander, MD, George Nteliopoulos, Mary Alikian, Jamshid S Khorashad, MD PhD, Letizia Foroni, MD PhD, Jane F. Apperley, FRCP, FRCPath, MD MBChB

Blood (2017) 130 (Supplement 1): 1628.

https://doi.org/10.1182/blood.V130.Suppl_1.1628.1628

Published: 2017

Journal Articles

Multi-Walled Carbon Nano-Tubes (MWCNTs) Accelerate Leukaemia Development in Mice: Implications for Drug Development in Humans

Bin Yin, PhD, Xiaofeng Han, PhD, Huikai Miao, Min Zhang, Yanwen Zheng, Huiquan Tao, Guangsong Su, Zhengwei Mao, Haiyan Xu, Hongchao Yin, Jiang Hu, Robert Peter Gale, MD ScD, PhD, Fanqing Chen

Blood (2017) 130 (Supplement 1): 5099.

https://doi.org/10.1182/blood.V130.Suppl_1.5099.5099

Published: 2017

Journal Articles

Clinical Entity and Outcomes of Therapy-Related Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: Surveillance By the Chronic Myeloid Leukemia Cooperative Study Group

Noriyoshi Iriyama, MDPhD, Tomoiku Takaku, MD, PhD, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, MD PhD, Hiroyuki Fujita, MD PhD, Michihide Tokuhira, MD PhD, Tatsuya Kawaguchi, MD PhD

Blood (2016) 128 (22): 3084.

https://doi.org/10.1182/blood.V128.22.3084.3084

Published: 2016

Journal Articles

Novel Flowcytometry-Based Approach for Detection of Tumor Cells in Body Fluid Using Automated Hematology Analyzer

Yoko Tabe, MD PhD, Hiroyuki Takemura, Konobu Kimura, Aya Konishi, Takashi Horii, Takashi Miida, MDPhD, Akimichi Ohsaka, MD PhD

Blood (2015) 126 (23): 5600.

https://doi.org/10.1182/blood.V126.23.5600.5600

Published: 2015

Journal Articles

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Ana Maria Hurtado, Eva Caparrós, Jose Miguel Torregrosa, Ginés Luengo, Mara Toderici, María Eugenia De la Morena, Begoña Muiña, Maria Luisa Lozano, Constant Martinez, Mari Luz Amigo, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Francisca Ferrer-Marin, MD, PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 5594.

https://doi.org/10.1182/blood.V124.21.5594.5594

Published: 2014

Journal Articles

Long Term Follow-Up After Imatinib Cessation For Patients Indeep Molecular Response: The Update Results Of The STIM1 Study

Francois-Xavier Mahon, MD, PhD, Delphine Rea, MD, PhD, Joelle Guilhot, PhD, Francois Guilhot, MD, Françoise Huguet, Franck E. Nicolini, MD, PhD, Laurence Legros, MD, PhD, Aude Charbonnier, MD, Agnès Guerci, MD, Bruno R. Varet, MD, Gabriel Etienne, MD, PHD, Josy Reiffers, MD, Philippe Rousselot, MD, PhD

Blood (2013) 122 (21): 255.

https://doi.org/10.1182/blood.V122.21.255.255

Published: 2013

Journal Articles

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Lorenzo Falchi, MD, Michael J. Keating, MD, Susan Lerner, MS, Xuemei Wang, MS, Sara S. Strom, PhD, William G. Wierda, MD, Alessandra Ferrajoli, M.D.

Blood (2012) 120 (21): 3896.

https://doi.org/10.1182/blood.V120.21.3896.3896

Published: 2012

Journal Articles

Histiocytis Sarcoma-Targeted Therapy: Novel Therapeutic Options? A Series of 4 Cases

Konstantin Schlick, Martin Pichler, Sonja Reitter, Peter Neumeister, Gerald Hoefler, Christine Beham-Schmid, Werner Linkesch, Dirk Strunk, Ariane Aigelsreiter

Blood (2011) 118 (21): 5005.

https://doi.org/10.1182/blood.V118.21.5005.5005

Published: 2011

Journal Articles

Targeting NEK2 Kinase In Drug-Resistant Multiple Myeloma with Small Molecule Inhibitors

Fenghuang Zhan, MD, PhD, Fang Xiao, PhD, Maurizio Zangari, MD, Hongwei Xu, MS, Benjamin Mughal, BS, Guido J. Tricot, MD, PhD

Blood (2010) 116 (21): 788.

https://doi.org/10.1182/blood.V116.21.788.788

Published: 2010

Journal Articles

Consistency and synergy

M. Jane Teta, Meghan E. Wagner

Blood (2009) 114 (9): 2000–2001.

https://doi.org/10.1182/blood-2009-05-219071

Published: 2009

Journal Articles

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma

Marie L. De Bruin, Jacobus A. Burgers, Paul Baas, Mars B. van 't Veer, Evert M. Noordijk, Marieke W. J. Louwman, Josée M. Zijlstra, Hendrik van den Berg, Berthe M. P. Aleman, Flora E. van Leeuwen

Blood (2009) 113 (16): 3679–3681.

https://doi.org/10.1182/blood-2008-10-184705

Published: 2009

Journal Articles

Incidence of Transformation to Large Cell Lymphoma and to Second Malignancies in Symptomatic Patients with Waldenstrom’s Macroglobulinemia (WM) Treated with Cladribine (2-CdA) Combination Induction Therapy

Ronjay Rakkhit, MD, Kay B Delasalle, B.S., Maria B. Gavino, R.N., Sheeba K. Thomas, Meletios A Dimopoulos, MD, Fredrick B. Hagemeister, MD, Maria Alma Rodriguez, MD, Peter McLaughlin, MD, Raymond Alexanian, MD, Donna M. Weber, MD

Blood (2008) 112 (11): 3065.

https://doi.org/10.1182/blood.V112.11.3065.3065

Published: 2008

Journal Articles

VG5Q Inhibition Suppresses Proliferation of Endothelial and Cancer Cell Lines

Vi dya Bodempudi, PhD, Olivia Anna Dudek, Kaoru Terai, Arkadiusz Zbigniew Dudek, MD, PhD, FACP

Blood (2008) 112 (11): 5464.

https://doi.org/10.1182/blood.V112.11.5464.5464

Published: 2008

Journal Articles

Pilot Study of a Wilms Tumor Protein (WT1) Heteroclitic Peptide Vaccine in Patients with Myeloid and Thoracic Neoplasms.

Peter G. Maslak, MD, Lee Krug, MD, Suzanne Chanel, RN, Tao Dao, PhD, Leonard James, MD, PhD, Leslie Tyson, RN, Sara Bekele, BA, David A. Scheinberg, MD, PhD

Blood (2007) 110 (11): 903.

https://doi.org/10.1182/blood.V110.11.903.903

Published: 2007

Journal Articles

CD4+ Peptide Epitopes from the WT1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Leukemia and Solid Tumor Cells.

Rena J. May, PhD, Javier Pinilla, MD PhD, Tatyana Korontsvit, Victoriya Zakhaleva, Ronghua H. Zhang, Tao Dao, MD PhD, Peter Maslak, MD, David A. Scheinberg, MD PhD

Blood (2006) 108 (11): 3706.

https://doi.org/10.1182/blood.V108.11.3706.3706

Published: 2006

Journal Articles

Proteinase-Activated Receptor 1, 3 Expression in Primary Human Carcinoma Cells.

Wan-Zhuo Xie, He Huang, Zhen Cai, Mao-Fang Lin, Frank Gieseler

Blood (2005) 106 (11): 4113.

https://doi.org/10.1182/blood.V106.11.4113.4113

Published: 2005

Journal Articles

Exhaled Nitric Oxide (eNO) and Pulmonary Function after Total Body Irradiation (TBI) Based Non Myeloablative Conditioning Regimens and Allogeneic Hematopoietic Cell Transplant.

Luisa Giaccone, MD, Caterina B. Bucca, MD, Roberto Sorasio, MD, Marcello Rotta, MD, Gabriele Aitoro, MD, Erica Panaro, MD, Luisa Brussino, MD, Giovanni Rolla, MD, Mario Boccadoro, MD, Benedetto Bruno, MD, PhD

Blood (2005) 106 (11): 5311.

https://doi.org/10.1182/blood.V106.11.5311.5311

Published: 2005

NARROW

Marked paraneoplastic leukemoid reaction in a patient with mesothelioma mimicking a myeloid neoplasm

Chimeric Antigen Receptor T Cell Therapy Pipeline at a Glance: A Retrospective and Systematic Analysis from Clinicaltrials.Gov

Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia

10-Year Outcome of Chronic Myeloid Leukemia Patients Resistant to Frontline Imatinib

Multi-Walled Carbon Nano-Tubes (MWCNTs) Accelerate Leukaemia Development in Mice: Implications for Drug Development in Humans

Clinical Entity and Outcomes of Therapy-Related Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: Surveillance By the Chronic Myeloid Leukemia Cooperative Study Group

Novel Flowcytometry-Based Approach for Detection of Tumor Cells in Body Fluid Using Automated Hematology Analyzer

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Long Term Follow-Up After Imatinib Cessation For Patients Indeep Molecular Response: The Update Results Of The STIM1 Study

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Histiocytis Sarcoma-Targeted Therapy: Novel Therapeutic Options? A Series of 4 Cases

Targeting NEK2 Kinase In Drug-Resistant Multiple Myeloma with Small Molecule Inhibitors

Consistency and synergy

Malignant mesothelioma after radiation treatment for Hodgkin lymphoma

Incidence of Transformation to Large Cell Lymphoma and to Second Malignancies in Symptomatic Patients with Waldenstrom’s Macroglobulinemia (WM) Treated with Cladribine (2-CdA) Combination Induction Therapy

VG5Q Inhibition Suppresses Proliferation of Endothelial and Cancer Cell Lines

Pilot Study of a Wilms Tumor Protein (WT1) Heteroclitic Peptide Vaccine in Patients with Myeloid and Thoracic Neoplasms.

CD4+ Peptide Epitopes from the WT1 Oncoprotein Stimulate CD4+ and CD8+ T Cells That Recognize and Kill Leukemia and Solid Tumor Cells.

Proteinase-Activated Receptor 1, 3 Expression in Primary Human Carcinoma Cells.

Exhaled Nitric Oxide (eNO) and Pulmonary Function after Total Body Irradiation (TBI) Based Non Myeloablative Conditioning Regimens and Allogeneic Hematopoietic Cell Transplant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only